Common Stock, Shares, Outstanding of HealthLynked Corp from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
HealthLynked Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • HealthLynked Corp Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 2,847,873, a 99% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

HealthLynked Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,847,873 -279,099,278 -99% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 281,947,151 0 0% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 281,947,151 +882,193 +0.31% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 2,821,877 -273,143,081 -99% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 281,947,151 +16,388,041 +6.2% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 281,947,151 +17,117,595 +6.5% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 281,064,958 +21,912,069 +8.5% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 275,964,958 +20,024,569 +7.8% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 265,559,110 +17,701,485 +7.1% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 264,829,556 +25,749,128 +11% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 259,152,889 +21,119,772 +8.9% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 255,940,389 +18,046,916 +7.6% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 247,857,625 +12,153,796 +5.2% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 239,080,428 +10,304,331 +4.5% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 238,033,117 +11,957,736 +5.3% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 237,893,473 +49,925,592 +27% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 235,703,829 +68,876,005 +41% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 228,776,097 +97,524,322 +74% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 226,075,381 +107,188,213 +90% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 187,967,881 +78,073,391 +71% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 166,827,824 +63,238,709 +61% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 131,251,775 +30,183,234 +30% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 118,887,168 +25,310,149 +27% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 109,894,490 +24,715,588 +29% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 103,589,115 +21,052,222 +26% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 101,068,541 +23,119,050 +30% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 93,577,019 +21,274,082 +29% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 85,178,902 +12,875,965 +18% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 82,536,893 +11,860,639 +17% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 77,949,491 +7,829,186 +11% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 72,302,937 +4,449,297 +6.6% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 72,302,937 +6,549,297 +10% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 70,676,254 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 70,120,305 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 67,853,640 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 65,753,640 31 Dec 2016 10-K 02 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.